Dokumendiregister | Ravimiamet |
Viit | REP-1/1807-1 |
Registreeritud | 17.05.2024 |
Sünkroonitud | 20.05.2024 |
Liik | Sissetulev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Labor) |
Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: neljapäev, 25. aprill 2024 15:39 Adressaat: Signe Leito Teema: For action: Proposed deletion of Diclazuril for veterinary use from the WP of Group 10B: EDQM-2024-01763-mail
Please make sure to include in any reply our mail reference: EDQM-2024-01763-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed deletion of Diclazuril for veterinary use (1718) from the work programme of Group 10B. In order to have access to the survey, please copy and paste the link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=546484&newtest=Y&lang=en Deadline for replies: 28 May 2024 Thank you. With kind regards On behalf of Dr Sylvina Iossiphova Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Stay connected with the EDQM
**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2024-01763-mail
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|